Literature DB >> 23483352

Elevation of tumor necrosis factor α in dorsal root ganglia and spinal cord is associated with neuroimmune modulation of pain in an animal model of multiple sclerosis.

F Begum1, W Zhu, C Cortes, B MacNeil, M Namaka.   

Abstract

Neuropathic pain (NPP) is a frequently reported symptom described by 50-80% of multiple sclerosis (MS) patients. Although Th1 cell activation is known to drive the pathology of MS, this critical step has also been suggested to be involved in the neuroimmune induction of NPP. The release of pain inducing inflammatory cytokines such as tumour necrosis factor alpha (TNFα) from activated Th1 cells may have key implications in the development of MS-induced pain. We hypothesize that immune mediated antigenic induction of inflammatory cytokines such as TNFα within dorsal root ganglia (DRG) and spinal cord (SC) facilitate the cellular events underlying induction of pain. A rat experimental autoimmune encephalomyelitis (EAE) model of MS was utilized to identify the cellular source and expression changes of TNFα protein and mRNA in the DRG and SC. The TNFα levels in the DRG and SC were correlated with the behavioral testing indicative of NPP. We show significant increases in TNFα protein and mRNA expression in DRG and SC of EAE animals at 12 days post induction (EAE12) relative to naïve control (NC) and active control (AC) groups. Further, we show increased TNFα protein and mRNA expression at the dorsal root entry point, which suggests the anterograde transport of both protein and mRNA. Further, the onset of NPP coincides with increased TNFα expression in the SC. These results demonstrate that the elevated expression of TNFα in the DRG and SC may be associated with the pathological induction of NPP in an animal model of MS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23483352     DOI: 10.1007/s11481-013-9449-5

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  57 in total

1.  Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release.

Authors:  Robert N Spengler; Reeteka Sud; Paul R Knight; Tracey A Ignatowski
Journal:  Neuropharmacology       Date:  2006-10-18       Impact factor: 5.250

Review 2.  Multiple sclerosis-related central pain disorders.

Authors:  Turo J Nurmikko; Sameer Gupta; Kate Maclver
Journal:  Curr Pain Headache Rep       Date:  2010-06

3.  Tumor necrosis factor-α increases brain-derived neurotrophic factor expression in trigeminal ganglion neurons in an activity-dependent manner.

Authors:  E Bałkowiec-Iskra; A Vermehren-Schmaedick; A Balkowiec
Journal:  Neuroscience       Date:  2011-02-16       Impact factor: 3.590

4.  Absence of C-C motif chemokine ligand 5 in mice leads to decreased local macrophage recruitment and behavioral hypersensitivity in a murine neuropathic pain model.

Authors:  Jiin-Tarng Liou; Hui-Bih Yuan; Chih-Chieh Mao; Ying-Shu Lai; Yuan-Ji Day
Journal:  Pain       Date:  2012-04-10       Impact factor: 6.961

Review 5.  The induction of pain: an integrative review.

Authors:  M J Millan
Journal:  Prog Neurobiol       Date:  1999-01       Impact factor: 11.685

Review 6.  Involvement of inflammatory mediators in neuropathic pain caused by vincristine.

Authors:  Norikazu Kiguchi; Takehiko Maeda; Yuka Kobayashi; Fumihiro Saika; Shiroh Kishioka
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

7.  Central pain in multiple sclerosis - sensory abnormalities.

Authors:  A Osterberg; J Boivie
Journal:  Eur J Pain       Date:  2009-04-08       Impact factor: 3.931

8.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

Review 9.  Assessment of neuropathic pain in cancer patients.

Authors:  Deborah T Blumenthal
Journal:  Curr Pain Headache Rep       Date:  2009-08

10.  PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination.

Authors:  Emma E Frost; Joseph A Nielsen; Tuan Q Le; Regina C Armstrong
Journal:  J Neurobiol       Date:  2003-02-15
View more
  14 in total

Review 1.  Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).

Authors:  Tina KhorshidAhmad; Crystal Acosta; Claudia Cortes; Ted M Lakowski; Surendiran Gangadaran; Michael Namaka
Journal:  Mol Neurobiol       Date:  2015-01-13       Impact factor: 5.590

2.  IL-1β Is Involved with the Generation of Pain in Experimental Autoimmune Encephalomyelitis.

Authors:  David Henrique Rodrigues; Bruno Pereira Leles; Vivian Vasconcelos Costa; Aline Silva Miranda; Daniel Cisalpino; Dawidson Assis Gomes; Danielle Glória de Souza; Antônio Lúcio Teixeira
Journal:  Mol Neurobiol       Date:  2015-11-28       Impact factor: 5.590

3.  Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.

Authors:  Noémie Frezel; Fabien Sohet; Richard Daneman; Allan I Basbaum; Joao M Braz
Journal:  Exp Neurol       Date:  2016-06-23       Impact factor: 5.330

4.  Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.

Authors:  Suzanne Doolen; Tommaso Iannitti; Renee R Donahue; Benjamin C Shaw; Carolyn M Grachen; Bradley K Taylor
Journal:  Pain       Date:  2018-02       Impact factor: 7.926

5.  Elevated expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the dorsal root ganglia and spinal cord in experimental autoimmune encephalomyelitis: implications in multiple sclerosis-induced neuropathic pain.

Authors:  Wenjun Zhu; Crystal Acosta; Brian MacNeil; Claudia Cortes; Howard Intrater; Yuewen Gong; Mike Namaka
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

6.  Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.

Authors:  Alice Valentin-Torres; Carine Savarin; David R Hinton; Timothy W Phares; Cornelia C Bergmann; Stephen A Stohlman
Journal:  J Neuroinflammation       Date:  2016-02-22       Impact factor: 8.322

7.  Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis.

Authors:  Samuel S Duffy; Chamini J Perera; Preet G S Makker; Justin G Lees; Pascal Carrive; Gila Moalem-Taylor
Journal:  Front Immunol       Date:  2016-09-22       Impact factor: 7.561

8.  Peripheral sensory neuron injury contributes to neuropathic pain in experimental autoimmune encephalomyelitis.

Authors:  I-Ching Wang; Chen-Yen Chung; Fang Liao; Chih-Cheng Chen; Cheng-Han Lee
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

9.  Neuropathic pain in animal models of nervous system autoimmune diseases.

Authors:  David H Tian; Chamini J Perera; Gila Moalem-Taylor
Journal:  Mediators Inflamm       Date:  2013-05-08       Impact factor: 4.711

Review 10.  Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models.

Authors:  Nemat Khan; Maree T Smith
Journal:  Inflammopharmacology       Date:  2014-02       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.